|
Volumn 42, Issue 3, 2014, Pages 179-184
|
Redox therapy in neonatal sepsis: reasons, targets, strategy, and agents
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
ANTIOXIDANT;
REACTIVE OXYGEN METABOLITE;
ANIMAL;
CRITICAL ILLNESS;
DRUG EFFECTS;
HUMAN;
INFANT, NEWBORN, DISEASES;
METABOLISM;
NEONATAL INTENSIVE CARE UNIT;
NEWBORN;
NEWBORN INTENSIVE CARE;
OXIDATION REDUCTION REACTION;
OXIDATIVE STRESS;
PATHOPHYSIOLOGY;
SEPSIS;
TREATMENT OUTCOME;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
ANTIOXIDANTS;
CRITICAL ILLNESS;
HUMANS;
INFANT, NEWBORN;
INFANT, NEWBORN, DISEASES;
INTENSIVE CARE UNITS, NEONATAL;
INTENSIVE CARE, NEONATAL;
OXIDATION-REDUCTION;
OXIDATIVE STRESS;
REACTIVE OXYGEN SPECIES;
SEPSIS;
TREATMENT OUTCOME;
|
EID: 85027930403
PISSN: None
EISSN: 15400514
Source Type: Journal
DOI: 10.1097/SHK.0000000000000198 Document Type: Review |
Times cited : (24)
|
References (0)
|